Open Access Open Access  Restricted Access Subscription or Fee Access

Potential of Novel Carriers for Effective Management of Acetaminophen Induced Hepatotoxicity

Archana Dhyani, Divya Juyal

Abstract


Liver is a vital organ of the human body. It plays an important role in the human body. Acetaminophen when taken in therapeutic doses, it is used in the treatment of various conditions. Hepatotoxicity is the prime factor responsible for drug withdrawal from the market. There is no doubt that hepatotoxicity requires considerable attention and that every viable measure be taken towards an efficient mechanism for hepatoprotection. The overdose of acetaminophen causes acute liver failure. The hepatotoxicity can be treated by targeting the liver by the various carriers like liposomes, nanoparicles, phytosomes etc. However the hepatoprotective therapies require better targeting, stability and better bioavailability. Such focus areas can be effectively met with the aid of lipid based delivery systems which can prove to be a breakthrough in the field of hepatoprotection.

Keywords: Hepatotoxicity, acetaminophen, acute liver failure

Keywords


Hepatotoxicity,acetaminophen,acute liver failure

Full Text:

PDF

References


REFERENCES

Makin A.J., Williams R. Acetaminophen-Induced Hepatotoxicity: Predisposing Factors and Treatments. Adv Intern Med.1997, 42: 453–83p.

Lee W.M. Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the Risks of Hepatic Failure. Hepatology. 2004, 40: 6–9p.

Lee W.M. Drug-Induced Hepatotoxicity. N Engl J Med.1995, 333: 1118–27p.

Dargan P.I., Jones A.L. Acetaminophen Poisoning: An Update for the Intensivist. Crit Care. 2002; 6:108–10p.

Larson A.M. Acetaminophen Hepatotoxicity. Clin Liver Dis.2007, 11: 525–48p.

Jones A.L. Mechanism of Action and Value of N-acetylcystein in the Treatment of Early and Late Acetaminophen Poisoning: A Critical Review. J Toxicol Clin Toxicol. 1998, 36: 277–85p.

James L.P., Mayeux P.R., Hinson J.A. Acetaminophen-Induced Hepatotoxicity. Drug Metab Dispos. 2003, 31: 1499–1506p.

Jaeschke H, Bajt ML. Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death. Toxicol Sci. 2006, 89: 31–41p.

Jaeschke H., Knight T.R., Bajt M.L. The Role of Oxidant Stress and Reactive Nitrogen Species in Acetaminophen Hepatotoxicity. Toxicol Lett. 2003, 144: 279–88p.

Liu Z.X., Kaplowitz N. Role of Innate Immunity in Acetaminophen-Induced Hepatotoxicity. Expert Opin Drug Metab.Toxicol. 2006, 2: 493–503p.

Salgia A.D., Kosnik S.D. When Acetaminophen Use Becomes Toxic, Treating Acute Accidental and Intentional Overdose. Postgrad Med. 1999, 105: 81–4p.

Singh D., Rawat M.S., Semalty A., et al. Quercetin-Phospholipid Complex: An Amorphous Pharmaceutical System in Herbal Drug Delivery. Curr Drug Discov Technol. 2011, 3: 76–8p.

Ajazuddin S.S. Applications of Novel Drug Delivery System for Herbal Formulations. Fitoterapia, 2010, 81: 680–9p.

Gasco MR. Solid Lipid Nanospheres Form Warm Microemulsions. Pharm. Technol. Eur. 1997. 9: 32–42p.

Yen F., Wu T.H., Lin G.T., et al. Nanoparticles Formulation of Cuscuta chinensis Prevents Acetaminophen-Induced

Hepatotoxicity in Rats. Food and Chemical Toxico. 2008, 46: 1771–7p.

Yanyu X., Yunmei S., Zhipeng C., et al. The preparation of Silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm. 2006, 307: 77–82p.




DOI: https://doi.org/10.37628/ijan.v1i1-2.15

Refbacks

  • There are currently no refbacks.